MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: MMS_Medical_Surgical Training & Simulation
Osso VR
Industry: Silicon Valley, California
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS)*
Organization & Developments: Corvus
Parents
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS)*
Children
2018: Corvus Pharmaceuticals: A New Immunotherapy Player_seekingalpha.com
2019: Corvus Pharmaceuticals: Insider Buying Ahead Of Potential Turnaround In Second Half Of 2019_seekingalpha.com
2020: Biotech Analysis Central Preview Series: Corvus Pharmaceuticals
2020: Corvus Shoots Up 115% On Start Of Novel Immunotherapy Study In Covid-19 Patients_www.tipranks.com
2021: Undervalued Based On COVID-19 Opportunity And Oncology Assets
2023: Corvus Pharmaceuticals: Targeting $1 Billion/Year U.S. T-Cell Lymphoma Market_ seekingalpha.com
2024: Corvus Pharma Reports $41.7M Cash Position, Advances Key Clinical Trials Despite Q3 Loss
2024: Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting
2024: Corvus Pharmaceuticals: The Market Likes The Story
2024: Corvus: Early Atopic Dermatitis Data Signals More Questions Than Answers (Rating Downgrade)
2025: Corvus Pharmaceuticals: Multiple Opportunities, But Plenty Of Risk
2025: Corvus Pharmaceuticals: Small Market, Many Competitors, Low Cash Balance
Jumps
*Key People: Corvus
Finance & Acquisitions: Corvus